Boston Scientific CapEx increased by 93.9% to $351.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 26.7%, from $277.00M to $351.00M. Over 4 years (FY 2021 to FY 2025), CapEx shows an upward trend with a 12.1% CAGR.
An increase signals growth investment or infrastructure modernization; a decrease might suggest cost-cutting or a transition to an asset-light model.
Funds used by a company to acquire, upgrade, and maintain physical assets such as property, plants, buildings, technolog...
Hardware-focused tech firms typically have higher CapEx relative to revenue than pure software companies due to manufacturing and supply chain needs.
cf_capital_expenditures| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $106.00M | $107.00M | $266.00M | $121.00M | $105.00M | $150.00M | $212.00M | $111.00M | $143.00M | $190.00M | $267.00M | $179.00M | $155.00M | $179.00M | $277.00M | $187.00M | $157.00M | $181.00M | $351.00M |
| QoQ Change | — | +0.9% | +148.6% | -54.5% | -13.2% | +42.9% | +41.3% | -47.6% | +28.8% | +32.9% | +40.5% | -33.0% | -13.4% | +15.5% | +54.7% | -32.5% | -16.0% | +15.3% | +93.9% |
| YoY Change | — | — | — | — | -0.9% | +40.2% | -20.3% | -8.3% | +36.2% | +26.7% | +25.9% | +61.3% | +8.4% | -5.8% | +3.7% | +4.5% | +1.3% | +1.1% | +26.7% |